Cardiovascular benefits associated with some GLP-1 receptor agonists (semaglutide, dulaglutide, liraglutide) observed in clinical trials are likely to diminish after discontinuation, though the exact persistence of these benefits remains uncertain
Lyle advises patients individually on when they have reached the right point to safely and effectively proceed with surgery
Eto H, Kato H, Suga H, Aoi N, Doi K, Kuno S, Yoshimura K
Wu, W., Geng, H., Liu, Z., Li, H
''We've learned from people on weight loss journeys including those on GLP-1 medications that they experience decreased appetite and thoughts of food,'' said Dominique R